Company profilePharmaceutical#260 of 1,318 in Pakistan1 DRAP alert

ISIS PHARMACEUTICAL

Pharmaceutical company · 70 brands · 64 molecules

Ranked #33 of 213 companies in Other Beta-Lactam, Cephalosporins & Penems

70 registered products 22 pharmaceutical brands 64 distinct molecules 1 DRAP alert

Company overview

registered products

pharmaceutical brands

distinct molecules

therapeutic classes

DRAP alerts

ISIS PHARMACEUTICAL is a pharmaceutical manufacturer registered with the Drug Regulatory Authority of Pakistan, holding 70 product registrations across 64 distinct molecules. Its portfolio is concentrated in Other Beta-Lactam, Cephalosporins & Penems and Anti-Infective, Ophthalmologicals. DRAP has issued 1 alert involving its products.

Compiled from the DRAP registry, DRAP approved prices and DRAP alerts, with observed retail from DVAGO and Servaid. Data as of 2026-07-30.

Top molecules by brand count

Eye4 brands

Neomycin2 brands

Dexamethasone2 brands

Chloramphenicol2 brands

Ceftriaxone2 brands

Metronidazole2 brands

Diclofenac2 brands

Paracetamol2 brands

Flurbiprofen2 brands

Polymyxin B2 brands

Therapeutic classes

Price band (DRAP official ceilings)

Registered products priced by source

DVAGO1 products · Rs 95 – Rs 95

Median across source: Rs 95

Regulatory record

1 alert in the DRAP feed we track.

101. Recall Alert – Cream Kanadex-N (Batch # D7-22 & F7-27) – Substandard.

2025-10-24

Competitive set

Companies whose registered portfolio overlaps most with this one.

VALOR PHARMACEUTICALS22 shared molecules

GLOBAL BRANDS DISTRIBUTORS21 shared molecules

Pfizer Laboratories (Pvt) Ltd.21 shared molecules

ZAFA PHARMACEUTICAL LABORATORIES (PVT) LTD.20 shared molecules

REMINGTON PHARMACEUTICAL INDUSTRIES (PVT) LTD.20 shared molecules

VENUS PHARMA19 shared molecules

HELIX PHARMA (PRIVATE) LIMITED18 shared molecules

EPHARM LABORATORIES18 shared molecules

MEDIATE PHARMACEUTICALS (PVT) LTD17 shared molecules

Atco Pharma International (Pvt) Ltd17 shared molecules

Get the full profile for ISIS

This page is a summary. The full company brief adds every registration with its approved ceiling and approval date, per-molecule competitive position, price positioning against the category, and a launch shortlist built from the whitespace above.

Request this brief See what’s included